Industry Information

Update May 27, 2021

Heavy! The world's first phase III clinical data of the new crown inactivated vaccine is officially released

On May 26, the international medical journal "The Journal of the American Medical Association" (The Journal of the American Medical Association, JAMA, IF45.54) published the "Two Novel Coronavirus...

Update May 26, 2021

Domestically-made innovative collectives go to sea, and clinical data of a number of blockbuster studies have been announced! Hengrui, Hausen...

一. Overview The ASCO annual meeting is known as the "Oscar Ceremony" of international oncology, and the research that is selected for the Oral Abstract Session every year is particularly concerned by...

Update May 20, 2021

Check out over 100 antibody drugs approved by the FDA! Double antibody, ADC...Where is the new flashpoint?

Since the US FDA approved the first monoclonal antibody OKT3 (muromonab-CD3) in 1986, it has a history of 35 years. Today, antibody drugs account for one-fifth of new drugs approved by the FDA each...

Update May 19, 2021

"Magic bullet" ADC drug 10 billion gold track competition intensifies! Domestic catch-up is accelerating, 2 models have been declared for listing, Genting Xinyao, Rongchang Bio...

Recently, the domestic news on the development of ADC drug research and development has been refreshed On May 18, the innovative ADC introduced by Xinma Biology is planned to be included in the...

Update May 18, 2021

60 billion market size! The fifth batch of centralized procurement of large varieties and leading companies gathered; Pfizer, AstraZeneca, Hengrui, Kelun, Chia Tai Tianqing...

Recently, Shanghai Sunshine Pharmaceutical Purchasing Network issued the "Notice on the Implementation of the Fifth Batch of National-Organized Drug Centralized Procurement of Drug Information...

Update May 17, 2021

This pharmaceutical field ushered in a R&D boom

On May 7, Eimerizumab was approved for the second indication-routine preventive treatment for adults and children with hemophilia A without inhibitors of coagulation factor VIII. The approval of this...

Update May 13, 2021

The transformation of Chinese medicine companies: 8 companies have revenues of over 10 billion yuan, and 23 companies have invested more than 100 million yuan in R&D

Among the six major pharmaceutical segments in the A-share market, traditional Chinese medicine and pharmaceutical business (pharmaceutical circulation) have been at the lowest valuations for many...

Update May 11, 2021

Heavy! Sinopharm Zhongsheng New Crown Vaccine Obtained Emergency Use Authorization by WHO

On May 7, the Director-General of the World Health Organization (WHO) Tan Desai announced that the new coronavirus inactivated vaccine (Vero cell) developed and produced by the Beijing Institute of...

Update May 10, 2021

Another 65 varieties have been reviewed! Hengrui has reviewed several blockbuster injections, Qilu, Zhengda Tianqing...

Highlights: In April, CDE added 59 new acceptance numbers (43 varieties). In April, there were 109 approvals (including deemed approval) involving 65 varieties of over-evaluation. According to the...

Update May 09, 2021

In 2025, global medical expenditures will reach US$1.6 trillion, and 20 therapeutic areas will increase at a rate of growth rate, including immunology, oncology, neurology...

Recently, according to the latest report of the IQVIA Institute of Human Data Science, "Outlook 2025: Global Medical Expenditure and Use Trends", global pharmaceutical expenditures (using invoice...